JY
USNA icon

Jeff Yass’s Usana Health Sciences USNA Stock Holding History

Jeff Yass’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,000
Closed -$315K – 13193
2023
Q1 		$315K Buy
+5,000
New +$298K ﹤0.01% 9619
2022
Q1 		– Sell
-4,800
Closed -$486K – 14031
2021
Q4 		$486K Sell
4,800
-4,100
-46% -$409K ﹤0.01% 9292
2021
Q3 		$821K Buy
8,900
+4,800
+117% +$462K ﹤0.01% 8067
2021
Q2 		$420K Sell
4,100
-3,000
-42% -$301K ﹤0.01% 10001
2021
Q1 		$693K Buy
7,100
+3,300
+87% +$300K ﹤0.01% 8683
2020
Q4 		$293K Sell
3,800
-100
-3% -$7.74K ﹤0.01% 9306
2020
Q3 		$287K Sell
3,900
-500
-11% -$40.1K ﹤0.01% 8800
2020
Q2 		$323K Sell
4,400
-75,400
-94% -$5.91M ﹤0.01% 8228
2020
Q1 		$4.61M Buy
79,800
+69,300
+660% +$4.82M ﹤0.01% 2685
2019
Q4 		$825K Sell
10,500
-4,100
-28% -$302K ﹤0.01% 5908
2019
Q3 		$998K Buy
14,600
+5,400
+59% +$363K ﹤0.01% 5690
2019
Q2 		$731K Buy
9,200
+4,500
+96% +$357K ﹤0.01% 6413
2019
Q1 		$394K Buy
4,700
+1,800
+62% +$188K ﹤0.01% 6730
2018
Q4 		$341K Sell
2,900
-1,400
-33% -$162K ﹤0.01% 6767
2018
Q3 		$518K Sell
4,300
-2,000
-32% -$248K ﹤0.01% 6451
2018
Q2 		$726K Sell
6,300
-5,600
-47% -$613K ﹤0.01% 6058
2018
Q1 		$1.02M Sell
11,900
-19,900
-63% -$1.54M ﹤0.01% 5195
2017
Q4 		$2.35M Buy
31,800
+2,900
+10% +$194K ﹤0.01% 3618
2017
Q3 		$1.67M Buy
28,900
+20,700
+252% +$1.22M ﹤0.01% 4248
2017
Q2 		$526K Buy
+8,200
New +$505K ﹤0.01% 6546
2013
Q4 		– Sell
-49,600
Closed -$2.15M – 9365
2013
Q3 		$2.15M Sell
49,600
-60,000
-55% -$2.41M ﹤0.01% 3977
2013
Q2 		$3.97M Buy
+109,600
New +$3.33M ﹤0.01% 2925

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jeff Yass's USNA Position: Q1 2026 in Review

Jeff Yass sold out of Usana Health Sciences (USNA) in Q1 2026, closing a stake of 23,655 shares — an estimated $464K sold.

Jeff Yass first reported a position in USNA in Q3 2013 and held it in 24 quarters. The position peaked at $6.94M in Q4 2014. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Jeff Yass reported no remaining Usana Health Sciences position as of Q1 2026 after selling out during the quarter.
  • Jeff Yass sold 23,655 Usana Health Sciences shares in Q1 2026, an estimated $464K.
  • Jeff Yass first reported a position in Usana Health Sciences in Q3 2013 and held it in 24 quarters.
  • Jeff Yass's Usana Health Sciences position peaked at $6.94M in Q4 2014.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.